miR-146a constitutes an endogenous feedback system to counteract the oncogenic potential of dysregulated signalling pathways in human glioblastomas, such as activation of EGFR (endothelial growth factor receptor) and inactivation of Pten (phosphatase and tensin homolog) in gliomas. The gene discussed is EGFR; the disease is central nervous system cancer.